HNN3.0
Register
Register
Register

Project cooperationUpdated on 20 January 2026

A structural approach to personalized medicine

Principal investigator - Academia at Bar Ilan University

Ramat Gan, Israel

About

We are experts in determining the atomic structure of biologically relevant protein-protein complexes, providing us with valuable insight into the structural basis of disease. We can apply this knowledge towards patient stratification and decisions on therapeutic pathways given the disease-causing mutation of a particular patient. We anticipate that in collaboration with physicians, cell biologists, computational/AI specialists and lab/organ-on-chip experts we can be an important contributor to a successful submission.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Organisation

Bar Ilan University

University

Ramat Gan, Israel

Similar opportunities

  • Project cooperation

    Human-relevant bone marrow-on-chip and AI-guided NAMs to predict and prevent resistance to targeted therapies in hematologic malignancies

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Vladan Čokić

    Head of Department of molecular oncology at Institute for Medical Research University of Belgrade

    Belgrade, Serbia

  • Project cooperation

    Expertise offer: structural mapping of protein-protein interactions in health and disease

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Jordan Chill

    Principal investigator - Academia at Bar Ilan University

    Ramat Gan, Israel

  • Project cooperation

    NGS-based molecular diagnostics for lymphoproliferative diseases in Horizon Europe projects

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Silvia Angeletti

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy